NCT03904251 CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia Status TERMINATED Phase PHASE1
NCT03903822 Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT03901469 A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer Status TERMINATED Phase PHASE2
NCT03895372 A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT03885089 Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis) Status COMPLETED Phase N/A
NCT03885037 Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis) Status COMPLETED Phase N/A
NCT03884439 Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis) Status COMPLETED Phase N/A
NCT03878719 Study of the Combination of Binimetinib and Encorafenib in Adolescent Patients With Unresectable or Metastatic BRAF V600-mutant Melanoma Status TERMINATED Phase PHASE1
NCT03872453 Acute Treatment Trial in Adult Subjects With Migraines Status COMPLETED Phase PHASE2/PHASE3
NCT03871439 OPEN LABEL, 2-PERIOD STUDY, TO COMPARE BIO-AVAILABILITY OF 2 DIFFERENT FORMULATIONS OF PF-05221304 IN HEALTHY ADULTS Status COMPLETED Phase PHASE1
NCT03870919 Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients Status ACTIVE_NOT_RECRUITING Phase NA
NCT03864042 Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03861403 A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT03861273 A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03860506 Study Evaluating the Effects of PSI-697 on Platelets in Subjects Who Smoke Status COMPLETED Phase PHASE1
NCT03854903 WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor Status COMPLETED Phase PHASE1